Holders Conversion Rights. Subject to Section 3.2 and Section 2.1(b) and the mandatory conversion provisions therein, the Holder shall have the right, but not the obligation, to convert all or any portion of the then aggregate outstanding Principal Amount of this Note, together with interest and fees due hereon, into shares of Common Stock, subject to the terms and conditions set forth in this Article III. The Holder may exercise such right by delivery to the Borrower of a written Notice of Conversion pursuant to Section 3.3.
Appears in 1 contract
Holders Conversion Rights. Subject to Section 3.2 and Section 2.1(b) and the mandatory conversion provisions therein3.2, the Holder shall have the right, but not the obligationobligation at all times, to convert all or any portion of the then aggregate outstanding Principal Amount of this Note, together with interest and fees due hereon, into shares of Common Stock, subject to the terms and conditions set forth in this Article IIIIII at the rate of $1.00 per share of Common Stock (“Fixed Conversion Price”) as same may be adjusted pursuant to this Note and the Subscription Agreement. The Holder may exercise such right by delivery to the Borrower of a written Notice of Conversion pursuant to Section 3.3.
Appears in 1 contract
Sources: Convertible Note (BioMETRX)
Holders Conversion Rights. Subject to Section 3.2 and Section 2.1(b) and the mandatory conversion provisions therein2.2, the Holder Holders shall have the right, but not the obligation, to convert all or any portion of the then aggregate outstanding Principal Amount of this Term Note, together with interest and fees due hereon, into shares of Common Stock, subject to the terms and conditions set forth in this Article III. The Holder Holders may exercise such right by delivery to the Borrower of a written Notice of Conversion pursuant to Section 3.3. The shares of Common Stock to be issued upon such conversion are herein referred to as the “Conversion Shares.”
Appears in 1 contract
Sources: Secured Convertible Term Note (Corgenix Medical Corp/Co)
Holders Conversion Rights. Subject to Section 3.2 and Section 2.1(b) and the mandatory conversion provisions therein2.2, the Holder shall have the right, but not the obligation, to convert all or any portion of the then aggregate outstanding Amortizing Principal Amount of this Note, together with interest and fees due hereon, at the Fixed Conversion Price, as adjusted, into shares of Common Stock, subject to the terms and conditions set forth in this Article III. The Holder may exercise such right by delivery to the Borrower of a written Notice of Conversion pursuant to Section 3.3. The shares of Common Stock to be issued upon such conversion are herein referred to as the “Conversion Shares.”
Appears in 1 contract
Holders Conversion Rights. Subject to Section 3.2 and Section 2.1(b) and the mandatory conversion provisions therein2.2, the Holder shall have the right, but not the obligation, to convert all or any portion of the then aggregate outstanding Principal Amount of this Note, together with interest and fees due hereon, into shares of Common Stock, subject to the terms and conditions set forth in this Article III. The Holder may exercise such right by delivery to the Borrower Company of a written Notice of Conversion pursuant to Section 3.3. The shares of Common Stock to be issued upon such conversion are herein referred to as the "Conversion Shares."
Appears in 1 contract
Holders Conversion Rights. Subject to Section 3.2 and Section 2.1(b) and the mandatory conversion provisions therein3.2, the Holder shall have the right, but not the obligationobligation at all times, to convert all or any portion of the then aggregate outstanding Principal Amount of this Note, together with interest and fees due hereon, into shares of Common Stock, subject to the terms and conditions set forth in this Article IIIIII at the rate of 65% of the average of the lowest three volume weighted average prices of the shares during the preceding 10 day trading period prior to conversion. The Holder may exercise such right by delivery to the Borrower of a written Notice of Conversion pursuant to Section 3.33.2.
Appears in 1 contract
Sources: Convertible Note (Plangraphics Inc)
Holders Conversion Rights. Subject to Section 3.2 and Section 2.1(b) and the mandatory conversion provisions therein2.2, the Holder shall have the right, but not the obligationobligation at all times, to convert all or any portion of the then aggregate outstanding Principal Amount of this Note, together with interest and fees due hereon, into shares of Common Stock, subject to the terms and conditions set forth in this Article IIIII at the rate of $1.00 per share of Common Stock (“Fixed Conversion Price”) as same may be adjusted pursuant to this Note and the Subscription Agreement. The Holder may exercise such right by delivery to the Borrower of a written Notice of Conversion pursuant to Section 3.32.3.
Appears in 1 contract
Sources: Convertible Note (BioMETRX)
Holders Conversion Rights. Subject to Section 3.2 and Section 2.1(b) and the mandatory conversion provisions therein2.2, the Holder shall have the right, but not the obligation, to convert all or any portion of the then aggregate outstanding Principal Amount of this Note, together with interest and fees due hereon, at the Fixed Conversion Price, as adjusted, into shares of Common Stock, subject to the terms and conditions set forth in this Article III. The Holder may exercise such right by delivery to the Borrower of a written Notice of Conversion pursuant to Section 3.3.. The shares of Common Stock to be issued upon such conversion are herein referred to as the "Conversion Shares.æ
Appears in 1 contract